Cargando…
Addictovigilance contribution during COVID-19 epidemic and lockdown in France
Addictovigilance is a safety monitoring targeted at substances with potential for abuse and dependence. This vigilance was involved during the period of COVID-19 epidemic due to the significant changes in access to drugs and psychological disruption caused by the pandemic and lockdown. This article...
Autores principales: | Lapeyre-Mestre, Maryse, Boucher, Alexandra, Daveluy, Amélie, Gibaja, Valérie, Jouanjus, Emilie, Mallaret, Michel, Peyrière, Helene, Micallef, Joëlle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309935/ https://www.ncbi.nlm.nih.gov/pubmed/32660776 http://dx.doi.org/10.1016/j.therap.2020.06.006 |
Ejemplares similares
-
Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
por: Roussin, Anne, et al.
Publicado: (2022) -
Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019) -
Cannabis Use: Signal of Increasing Risk of Serious Cardiovascular Disorders
por: Jouanjus, Emilie, et al.
Publicado: (2014) -
Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
por: Tambon, Marine, et al.
Publicado: (2021) -
Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
por: Soeiro, Thomas, et al.
Publicado: (2021)